Inventor · disambiguated record
Hai-Yun Xiao
Also filed as: XIAO HAI-YUN
35 granted patents·3 pending applications·239 citations·filing 2000–2021
96Inventor score
Top patents by PatentIndex Score
38 records- 0197US6515004B1N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinasesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Feb 4, 2003·155 cites·59 claims
- 0291US10335392B2Cyclic compounds useful as modulators of TNF αBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jul 2, 2019·5 cites·10 claims
- 0390US10435369B2Tricyclic sulfones as ROR gamma modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 8, 2019·6 cites·6 claims
- 0490US7141578B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·17 cites·14 claims
- 0589US9359286B2Bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jun 7, 2016·7 cites·3 claims
- 0688US9115054B2Tetrahydronaphthalenyl compounds useful as sipi agonistsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 25, 2015·13 cites·20 claims
- 0782US10166249B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·2 cites·7 claims
- 0882US9458171B2Pyrrolidinyl sulfone RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 4, 2016·4 cites·14 claims
- 0982US7517904B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Apr 14, 2009·1 cites·3 claims
- 1081US9522888B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 20, 2016·2 cites·12 claims
- 1181US7417040B2Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3BRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·3 cites·13 claims
- 1278US11701373B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jul 18, 2023·0 cites·5 claims
- 1378US7550458B2Tricycloundecane compounds useful as modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 23, 2009·2 cites·11 claims
- 1476US6414156B2Process for preparing azacycloalkanoylaminothiazolesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 2, 2002·6 cites·34 claims
- 1575US11058696B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 13, 2021·0 cites·4 claims
- 1674US7655689B2Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 2, 2010·1 cites·13 claims
- 1774US6809102B2Cyano-substituted dihydropyrimidine compounds and their use to treat diseasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Oct 26, 2004·7 cites·32 claims
- 1872US10709719B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 14, 2020·0 cites·10 claims
- 1970US9216972B2Tricyclic heterocyclic compoundsDHAR T G MURALI·Filed 2010·Granted Dec 22, 2015·2 cites·16 claims
- 2070US8067447B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofSHEPPECK JAMES E·Filed 2007·Granted Nov 29, 2011·2 cites·12 claims
- 2170US6639074B2Process for preparing azacycloalkanoylaminothiazolesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Oct 28, 2003·3 cites·7 claims
- 2268US10865191B2Heterocyclic compounds useful as modulators of TNF alphaBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 15, 2020·1 cites·4 claims
- 2366US8013004B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Sep 6, 2011·0 cites·6 claims
- 2461US9770459B2Substituted bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 26, 2017·0 cites·17 claims
- 2559US9487481B2Bicyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 8, 2016·0 cites·3 claims
- 2656US7642273B2Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 5, 2010·0 cites·4 claims
- 2753US11059784B2Oxime ether compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 13, 2021·0 cites·13 claims
- 2851US2004077605A1Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor functionFiled 2002·Application pending·0 cites
- 2949US8309730B2Nonsteroidal compounds useful as modulators of glucocorticoid receptor AP-1 and/or NF-kappab acitivity and use thereofDHAR T G MURALI·Filed 2008·Granted Nov 13, 2012·0 cites·7 claims
- 3048US10633354B2Substituted tricyclic heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 28, 2020·0 cites·7 claims
- 3148US7994190B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 9, 2011·0 cites·14 claims
- 3244US8198311B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofSHEPPECK JAMES E·Filed 2007·Granted Jun 12, 2012·0 cites·9 claims
- 3343US7361654B2Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 22, 2008·0 cites·14 claims
- 3442US10308652B2Tricyclic heterocyclic compounds useful as inhibitors of TNFBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 4, 2019·0 cites·3 claims
- 3541US10934286B2Heterocyclic sulfones as ROR gamma modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 2, 2021·0 cites·20 claims
- 3641US2016326108A1Pyrrolidinyl sulfone derivatives and their use as ror gamma modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3740US2002165240A1Method of treating proliferative diseases using Eg5 inhibitorsFiled 2002·Application pending·0 cites
- 3834US10189840B2Substituted tricyclic heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 29, 2019·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Hai-Yun Xiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →